BMO Capital Initiates Coverage On RXO with Outperform Rating, Announces Price Target of $35

RXO, Inc. Common Stock

RXO, Inc. Common Stock

RXO

0.00

BMO Capital analyst Fadi Chamoun initiates coverage on RXO (NYSE: RXO) with a Outperform rating and announces Price Target of $35.